Advertisement
Screener

Taysha Gene Therapies, Inc. (TSHA) ROA

Taysha Gene Therapies, Inc. (TSHA) ROA

  • 2026-06-30: ROA -31.81%.
  • 2026-03-31: ROA -43.24%.
  • 2025-12-31: ROA -31.75%.
  • 2025-09-30: ROA -31.57%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-31.81%
2026-03-31-43.24%
2025-12-31-31.75%
2025-09-30-31.57%
2025-06-30-27.82%
2025-03-31-62.71%
2024-12-31-55.68%
2024-09-30-12.64%
2024-06-30-57.06%
2024-03-31-77.13%
2023-12-31-64.59%
2023-09-30-109.51%
2023-06-30-151.85%
2023-03-31-131.22%
2022-12-31-131.47%
2022-09-30-144.72%
2022-06-30-130.67%
2022-03-31-116.17%
2021-12-31-81.57%
2021-09-30-59.10%
2021-06-30-43.96%
2021-03-31-35.66%
2020-12-31-23.18%

Annual ROA

DateROA
2025-12-31-31.75%
2024-12-31-55.68%
2023-12-31-64.59%
2022-12-31-131.47%
2021-12-31-81.57%
2020-12-31-23.18%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immunocore Holdings plc (IMCR)$1.613B-90.43
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
NOVAVAX INC (NVAX)United States$1.748B-6.26
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Vericel Corp (VCEL)United States$2.011B93.97
Vor Biopharma Inc. (VOR)United States$1.091B1.60
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10